Existing investors Boehringer Ingelheim Venture Fund (BIVF), Reference Capital, multi-family office Wille Finance and several private investors have backed a CHF 25m round for cancer therapy developer T3 Pharmaceuticals.
Existing investors including Softbank and Lakestar reinvest in the tourism booking platform
Andera has reinvested and Prenax has acquired LM Information's subscription management business
Sale ends a six-year holding period for KCP, which backed the company with a £3.3m investment
Danish internet company could reportedly be listed at a valuation of $1bn